Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas

被引：0
|
作者：
Tamara Ius
Daniela Cesselli
Miriam Isola
Giovanni Toniato
Giada Pauletto
Giovanni Sciacca
Sara Fabbro
Enrico Pegolo
Simona Rizzato
Antonio Paolo Beltrami
Carla di Loreto
Miran Skrap
机构：
[1] Santa Maria della Misericordia University Hospital,Neurosurgery Unit, Department of Neurosciences
[2] University of Udine,Department of Medicine
[3] Santa Maria della Misericordia University Hospital,Neurology Unit, Department of Neurosciences
[4] Santa Maria della Misericordia University Hospital,Department of Oncology
[5] Santa Maria della Misericordia University Hospital,Institute of Pathology
来源：
Current Treatment Options in Neurology | 2018年 / 20卷
关键词：
Glioma surgery; Carmustine wafers; MGMT methylation; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Carmustine Implants for the Treatment of Newly Diagnosed High-Grade GliomasA Cost-Utility Analysis
    Gabriel Rogers
    Ruth Garside
    Stuart Mealing
    Martin Pitt
    Rob Anderson
    Matthew Dyer
    Ken Stein
    Margaret Somerville
    PharmacoEconomics, 2008, 26 : 33 - 44
  • [22] Tamoxifen and carboplatin combinational treatment of high-grade gliomas - Results of a clinical trial on newly diagnosed patients
    Mastronardi, L
    Puzzilli, F
    Couldwell, WT
    Farah, JO
    Lunardi, P
    JOURNAL OF NEURO-ONCOLOGY, 1998, 38 (01) : 59 - 68
  • [23] Tamoxifen and carboplatin combinational treatment of high-grade gliomas Results of a clinical trial on newly diagnosed patients
    Luciano Mastronardi
    Fabrizio Puzzilli
    William T. Couldwell
    Jibril Osman Farah
    Pierpaolo Lunardi
    Journal of Neuro-Oncology, 1998, 38 : 59 - 68
  • [24] Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
    Gallia, Gary L.
    Holdhoff, Matthias
    Brem, Henry
    Joshi, Avadhut D.
    Hann, Christine L.
    Bai, Ren-Yuan
    Staedtke, Verena
    Blakeley, Jaishri O.
    Sengupta, Soma
    Jarrell, T. Che
    Wollett, Jessica
    Szajna, Kelly
    Helie, Nicole
    Mattox, Austin K.
    Ye, Xiaobu
    Rudek, Michelle A.
    Riggins, Gregory J.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [25] The role of Gliadel wafers in the treatment of high-grade gliomas
    Bregy, Amade
    Shah, Ashish H.
    Diaz, Maria V.
    Pierce, Hayley E.
    Ames, Philip L.
    Diaz, Daniel
    Komotar, Ricardo J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (12) : 1453 - 1461
  • [26] Carmustine-impregnated wafers and their impact in the management of high-grade glioma
    La Rocca, Renato V.
    Rezazadeh, Arash
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1325 - 1332
  • [27] The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
    Gerber, David E.
    Grossman, Stuart A.
    Zeltzman, Michel
    Parisi, Michele A.
    Kleinberg, Lawrence
    NEURO-ONCOLOGY, 2007, 9 (01) : 47 - 52
  • [28] Benefits of adjuvant chemotherapy in high-grade gliomas
    DeAngelis, LM
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 15 - 18
  • [29] A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood
    Jakacki, Regina I.
    Yates, Allan
    Blaney, Susan M.
    Zhou, Tianni
    Timmerman, Robert
    Ingle, Ashish M.
    Flom, Lynda
    Prados, Michael D.
    Adamson, Peter C.
    Pollack, Ian F.
    NEURO-ONCOLOGY, 2008, 10 (04) : 569 - 576
  • [30] Feasibility of lymphocyte harvesting and reinfusion in patients with newly diagnosed high-grade gliomas.
    Campian, Jian Li
    Ye, Xiaobu
    Gladstone, Douglas Edward
    Ambady, Prakash
    Borrello, Ivan
    Golightly, Marc
    Karen, Karen E. King
    King, E.
    Holdhoff, Matthias
    Karp, Judith E.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345